☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AS
Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases
October 31, 2018
Novartis Receives EU Approval for Cosentyx's (secukinumab) Label Update in Patients with Psoriatic Arthritis (PsA)
October 26, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
